Buffy the asthma inhaler? Teva taps 'Vampire Slayer' actress to raise inhaler misuse awareness | FiercePharma
Teva Pharmaceuticals buys smart inhaler company Gecko Health Innovations | MobiHealthNews
Teva Canada commercialises Aermony RespiClick for bronchial asthma
FDA approves Teva's digital COPD, asthma inhaler - Drug Delivery Business
Teva Pharmaceuticals - Wikipedia
Teva Develops First FDA-Approved Digitally-Integrated Inhaler
Teva Pharmaceuticals USA - Teva is proud to support the #asthma patient community by providing an unrestricted education grant to Asthma and Allergy Foundation of America (AAFA), to help publish this special
Teva launches digital asthma and COPD rescue inhaler in US -
FDA Approves Two Breath-actuated Asthma Meds from Teva | RT
Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
Teva Pharmaceuticals USA - Home | Facebook
Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment | Medgadget
Teva Pharmaceuticals on Twitter: "#DYK: #Asthma costs the United States $56 billion each year. #ACAAI16… "
Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times
Teva digital asthma inhaler wins FDA nod - Globes
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva Launches 2 New Digital Maintenance Inhalers
Subcutaneous Cinqair results add to Teva's troubles
Teva's digital inhaler cleared by FDA | MobiHealthNews
Teva Announces FDA approval of AirDuo® Digihaler™
AirDuo Digihaler, a Digital Maintenance Asthma Inhaler Therapy, Gets FDA Approval - MPR
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
